Nucleus Network
Brisbane, Australia· Est.
Global early‑phase CRO delivering integrated Phase I trials for biotech and pharma sponsors.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Global early‑phase CRO delivering integrated Phase I trials for biotech and pharma sponsors.
OncologyImmunologyInfectious DiseasesVaccinesBiosimilars
Technology Platform
Integrated early‑phase clinical trial platform combining co‑located hospital sites, advanced pharmacokinetic capabilities, and a large digital participant recruitment database.
Opportunities
Expansion of digital recruitment tools and addition of early‑phase II capabilities can deepen client relationships and capture higher‑margin contracts.
Risk Factors
Intense competition from larger CROs and regulatory differences across regions could pressure pricing and enrollment timelines.
Competitive Landscape
Key competitors include ICON, Charles River, and Covance; Nucleus differentiates through its tri‑continental, co‑located Phase I sites and a proprietary participant database.